Biocon - Global Healthcare Company
 
About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Press Release
  > MEDIA
  Overview
  Featured News
  Press Release
  Archives
  Download Center
  Video Gallery
  Photo Gallery
  Media FAQs
  Media Contacts
  
  Home
  
     
 

News

  Press Releases

[1]      2     3     4     5     6     7     8     9     10     11     12     13     14     15     16     17     18     19     20    

Biocon-Mylan Programs Make Progress: PEG-G-CSF and Adalimumab enter Phase 3 clinical trials; Patient recruitment for one Insulin Glargine Phase 3 study completed
May 07, 2015
Read more...
Biocon top line grows 15% in Q4 FY15; Research Services delivers 27% growth; FY15 Revenues at Rs. 3143 Crore, PAT at Rs. 497 Crore
Apr 30, 2015
Read more...
Bioconís CRO Arm Syngene Seeks Approval for IPO, Files DRHP; Offer allows Biocon to monetize its shareholding in Syngene
Apr 28, 2015
Read more...
Biocon Strengthens its Presence in Mexico; Receives Approval for Insulin Glargine through its partner PiSA Farmaceutica
Apr 09, 2015
Read more...
Biocon Recognized for Outstanding Contribution to Public Health by WHO - India...
Apr 08, 2015
Read more...
Kiran Mazumdar-Shaw Honoured by Federation University Australia...
Mar 05, 2015
Read more...
Dr Jeremy Levin Joins Bioconís Board of Directors...
Jan 22, 2015
Read more...
Dr Vijay Kuchroo Joins Bioconís Board of Directors...
Jan 22, 2015
Read more...
Biocon Q3 FY15 Revenues at Rs. 779 Crore, PAT at Rs. 91 Crore;
Jan 22, 2015
Read more...
Biocon Expands its Strategic Partnership with CytoSorbents for CytoSorbģ to Treat SIRS and Cardiac Surgery Patients...
Nov 03, 2014
Read more...
[1]      2     3     4     5     6     7     8     9     10     11     12     13     14     15     16     17     18     19     20    
Results 1 - 10 of about 191
 
     
News
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer | Authorised Users               © 2015, Biocon. All Rights Reserved